Skip to content
On this page:OverviewPublicationsKey papers
PICO Portalanswers from OpenAlex & ORCID

Jonathan W. Friedberg

ResearcherPublications, citations & collaboration network

Jonathan W. Friedberg is a researcher indexed in PICO Portal from OpenAlex & ORCID.

How many works does Jonathan W. Friedberg have?

PICO Portalindexed works

Jonathan W. Friedberg has 727 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Jonathan W. Friedberg have?

PICO Portalcitation count

Jonathan W. Friedberg has 31,209 citations in the OpenAlex counts PICO Portal stores.

What is the h-index of Jonathan W. Friedberg?

PICO Portalh-index

Jonathan W. Friedberg has an h-index of 80 in OpenAlex.

What is the i10-index of Jonathan W. Friedberg?

PICO Portali10-index

Jonathan W. Friedberg has an i10-index of 290 in OpenAlex.

What is the ORCID of Jonathan W. Friedberg?

PICO Portalorcid

The ORCID for Jonathan W. Friedberg is on the source record.

What is the OpenAlex record for Jonathan W. Friedberg?

PICO Portalopenalex

The OpenAlex for Jonathan W. Friedberg is on the source record.

What are the most-cited papers on Jonathan W. Friedberg?

PICO Portalmost cited works
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou, Laurie H. Sehn, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Andrew D. Zelenetz, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Joyce C. Niland, Randy D. Gascoyne, Joseph M. Connors, Jonathan W. Friedberg, Jane N. Winter
Blood. 2013959 Citations
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo, Michelle Byrtek, Keith Dawson, Xiaolei Zhou, Charles M. Farber, Christopher R. Flowers, John D. Hainsworth, Matthew J. Maurer, James R. Cerhan, Brian K. Link, Andrew D. Zelenetz, Jonathan W. Friedberg
Journal of Clinical Oncology. 2015852 CitationsOPEN ACCESS
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, Tim Illidge, Michelle A. Fanale, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo‐Doménech, Giuseppe Rossi, Won Seog Kim, Tatyana Feldman, Anne Lennard, David Belada, Árpád Illés, Kensei Tobinai, Kunihiro Tsukasaki, Su‐Peng Yeh, Andrei R. Shustov, Andreas Hüttmann, Kerry J. Savage, Sam Yuen, Swaminathan P. Iyer, Pier Luigi Zinzani, Zhaowei Hua, Meredith Little, Shangbang Rao, Joseph Woolery, Thomas Manley, Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski
The Lancet. 2018730 CitationsOPEN ACCESS
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
Andrea K. Ng, Marializa Bernardo, Edie Weller, Kendall H. Backstrand, Barbara Silver, Karen Marcus, Nancy J. Tarbell, Mary Ann Stevenson, Jonathan W. Friedberg, Peter Mauch
Blood. 2002435 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial